Taking medicine in the right way – most important but most neglected

• Authors: Abdul Kader Mohiuddin

Abstracts

EN

Introduction and aim. To cure any disease, proper use of medicine or taking medicine in the correct order is required. Even patients from developed countries struggle to maintain their drug compliance. There is an odd parallel between underdeveloped, emerging nations and the so-called developed world in the West when it comes to improper medicine use. The understanding and perception of the disease is the most important factor influencing whether patients stick to their treatment plan. Material and methods. Prioritized databases for public health topics included PubMed, ALTAVISTA, Embase, Scopus, Web of Science, and the Cochrane Central Registers. Along with other online sources, journals from Elsevier, Springer, Willey Online Library, and Wolters Kluwer were thoroughly searched. Analysis of the literature. There is a thorough discussion of medication non-adherence issues and a few adherence-improving methods. Conclusion. Adherence to treatment guidelines is essential in the treatment of any disease.

Keywords

EN

medication non-adherence; patient non-compliance; avoidable medical costs

• Publisher: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
• Journal: European Journal of Clinical and Experimental Medicine
• Year: 2023
• Issue: 1
• Pages: 152-159

Dates

published

2023

Contributors

author

Abdul Kader Mohiuddin

• Alumni, Faculty of Pharmacy, Dhaka University, Dhaka, Bangladesh

• https://orcid.org/0000000315969757

References

• Grissinger M. The Five Rights: A Destination Without a Map. Physical Therapy-Oxford Academic. 2010;35(10):542.
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proceedings. 2011;86(4):304-314. doi: 10.4065/mcp.2010.0575.
• Center for Drug Evaluation and Research. Why you need to take your medications as prescribed or instructed. U.S. Food and Drug Administration. https://www. fda.gov/drugs/special-features/why-you-need-take-yourmedications-prescribed-or-instructed. Accessed November 5, 2022.
• Barnett NL. Medication adherence: where are we now? A UK perspective. Eur J Hosp Pharm. 2014;21:181-184. doi: 10.1136/ejhpharm-2013-000373.
• Record 6.8M people waiting for hospital treatment in England. The Guardian. http://www.theguardian.com/ society/2022/sep/08/waiting-lists-for-routine-hospitaltreatment-in-england-break-record. Published September 8, 2022. Accessed November 5, 2022.
• Andrews L. 60% of NHS patients have waited 18 weeks for treatment at worst-performing hospital trust. Daily Mail Online. http://www.dailymail.co.uk/news/article-10577387/60-NHS-patients-waited-18-weeks-treatment-worst-performing-hospital-trust.html. Published March 7, 2022. Accessed November 5, 2022.
• Mohiuddin AK. Chapter 14. Patient Compliance. The Role of the Pharmacist in Patient Care: Achieving High Quality, Cost-Effective and Accessible Healthcare Through a Team-Based, Patient-Centered Approach. Universal-Publishers; 2020:250-270.
• https://www.universal-publishers.com/book.php?method=ISBN&book=1627343083
• Cutler RL, Torres-Robles A, Wiecek E, et al. Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system. Patient Preference and Adherence. 2019;13:853-862. doi: 10.2147/PPA.S191482.
• Lim R, Ellett LM, Semple S, Roughead EE. The extent of medication-related hospital admissions in Australia: A review from 1988 to 2021. Drug Safety. 2022;45(3):249-257. doi: 10.1007/s40264-021-01144-1.
• Medication Nonadherence: Medicine’s Weakest Link. Wolters Kluwer, Health/Experts Insight, https://www.wolterskluwer.com/en/expert-insights/medication-nonadherence-medicines-weakest-link. Accesseed February 3, 2020.
• Kardas P, Bago M, Barnestein-Fonseca P, et al. Reimbursed medication adherence enhancing interventions in 12 European countries: Current state of the art and future challenges. Front Pharmacol. 2022;13:944829. doi:10.3389/ fphar.2022.944829
• van Boven JF, Tsiligianni I, Potočnjak I, et al. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021;12:748702. doi: 10.3389/fphar.2021.748702.
• Bonsu KO, Young S, Lee T, Nguyen H, Chitsike RS. Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada – A Cross-Sectional Survey. Patient Preference and Adherence. 2022;16:1771-1780. doi: 10.2147/PPA.S367105.
• Zhang Y, Flory JH, Bao Y. Chronic Medication Nonadherence and Potentially Preventable Healthcare Utilization and Spending Among Medicare Patients. J Gen Intern Med. 2022;37(14):3645-3652. doi: 10.1007/s11606-02107334-y. 157Case of multisystem in ammatory syndrome in adults
• Bulik BS. Nonadherence costs pharma $600B-plus in annual sales: Study. Fierce Pharma. https://www.fiercepharma.com/marketing/non-adherence-costs-healthcaresystem-patient-outcomes-and-pharma-bottom-line. Published November 22, 2016. Accessed November 24, 2022.
• Bahta M, Tesfamariam S, Weldemariam DG, et al. Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method. PLoS One. 2020;15(1):e0228013. doi: 10.1371/journal.pone.0228013.
• Improve antibiotic use. Centers for Disease Control and Prevention. https://www.cdc.gov/sixeighteen/hai/index. htm. Published March 9, 2022. Accessed November 18, 2022.
• Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. doi: 10.1016/ S0140-6736(21)02724-0.
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clinical Infectious Diseases-Oxford Academic. 2020;71(9):2459-2468. doi:10.1093/cid/ciaa530.
• Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clinical Infectious Diseases-Oxford Academic. 2020;71:2736-2743.
• Daria S, Islam MR. Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance. Clinical Pathology - SAGE Journals. 2022;15:2632010X221099889. doi: 10.1177/2632010X221099889.
• Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis. Clinical Microbiology and Infection. 2021;27:520531. doi: 10.1016/j.cmi.2020.12.018.
• Cong W, Poudel AN, Alhusein N, Wang H, Yao G, Lambert H. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. Antibiotics. 2021;10(6):745. doi: 10.3390/antibiotics10060745.
• Kamara IF, Kumar AMV, Maruta A, et al. Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy. Int J Environ Res Public Health. 2022;19(7):4005. doi: 10.3390/ijerph19074005.
• Usman M, Farooq M, Hanna K. Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19. Sci Total Environ. 2020;745:141053. doi: 10.1016/j.scitotenv.2020.141053.
• Kasciuškevičiūtė S, Gumbrevičius G, Vendzelytė A, Ščiupokas A, Petrikonis K, Kaduševičius E. Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study. Medicina. 2018;54(2):30. doi: 10.3390/medicina54020030.
• Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016;66(645):172-173. doi: 10.3399/ bjgp16X684433.
• Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Brazilian Journal of Nephrology. 2019;41(1):124-130. doi: 10.1590/2175-8239-JBN-2018-0107.
• Mohiuddin AK. Medication adherence: Fact or fictions? Current Research in Public Health. 2022;2(1):18-21. doi: 10.31586/crph.2022.533.
• Jahrami H, BaHammam AS, Bragazzi NL, Saif Z, Faris M, Vitiello MV. Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 2021;17(2):299-313. doi: 10.5664/ jcsm.8930.
• Ostuzzi G, Papola D, Gastaldon C, et al. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Medicine-Springer Nature. 2020;18(1):215. doi: 10.1186/s12916020-01685-9.
• Sarangi A, McMahon T, Gude J. Benzodiazepine Misuse: An Epidemic Within a Pandemic. Cureus. 2021;13(6):e15816. doi: 10.7759/cureus.15816.
• Bhadelia A, De Lima L, Arreola-Ornelas H, Kwete XJ, Rodriguez NM, Knaul FM. Solving the Global Crisis in Access to Pain Relief: Lessons From Country Actions. Am J Public Health. 2019;109(1):58-60. doi: 10.2105/ AJPH.2018.304769.
• Lopez G. Marijuana Majority/ Americans support marijuana legalization, but many of their political leaders do not. The New York Times. https://www.nytimes. com/2022/11/23/briefing/legal-weed-marijuana.html. Accessed November 23, 2022.
• Oltermann P. Germany announces plan to legalise cannabis for recreational use. The Guardian. https://www.theguardian.com/world/2022/oct/26/germany-to-legalisecannabis-for-recreational-use. Published October 26, 2022.
• Mohiuddin AK. Our low health literacy needs urgent fixing.https://www.thedailystar.net/opinion/views/news/ our-low-health-literacy-needs-urgent-fixing-3193246. Published December 11, 2022.
• Alam MM, Melhim LKB, Ahmad MT, Jemmali M. Public Attitude Towards COVID-19 Vaccination: Validation of COVID-Vaccination Attitude Scale (C-VAS). J Multidiscip Healthc. 2022;15:941-954. doi: 10.2147/JMDH.S353594.
• Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India - a community based survey. BMC Health Services Research. 2021;21(1):994. doi: 10.1186/s12913-021-07037-4. 158 European Journal of Clinical and Experimental Medicine 2023; 21 (1): 152–159
• Leelavathy M, Messaline S, Ramachandran D, Sukumaran A, Jose R, Noufel AN. Attitude towards COVID-19 vaccination among the public in Kerala: A cross sectional study. Fam Med Prim Care Rev. 2021;10(11):4147-4152. doi: 10.4103/jfmpc.jfmpc_583_21.
• Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. doi: 10.1016/j.lanepe.2020.100012.
• Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review. Heliyon. 2022;8(6):e09716. doi: 10.1016/j.heliyon.2022.e09716.
• Chong E, Wang H, King-Shier KM, Quan H, Rabi DM, Khan NA. Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with type 2 diabetes mellitus: a population-based cohort study. Diabetic Medicine. 2014;31(12):1586-1593. doi: 10.1111/dme.12559.
• Sohal T, Sohal P, King-Shier KM, Khan NA. Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review. PLoS One. 2015;10(9):e0136202. doi: 10.1371/journal.pone.0136202.
• Alsairafi ZK, Taylor KM, Smith FJ, Alattar AT. Patients’ management of type 2 diabetes in Middle Eastern countries: review of studies. Patient Preference and Adherence. 2016;10:1051-62. doi: 10.2147/PPA.S104335.
• Almigbal TH, Almutairi KM, Vinluan JM, et al. Association of health literacy and self-management practices and psychological factor among patients with type 2 diabetes mellitus in Saudi Arabia. Saudi Medical Journal. 2019;40(11):1158-1166. doi: 10.15537/smj.2019.11.24585.
• Nair SC, Sreedharan J, Satish KP, Ibrahim H. Health literacy in a high income Arab country: A nation-wide cross-sectional survey study. PLoS One. 2022;17(10):e0275579. doi: 10.1371/journal.pone.0275579.
• Hashim SA, Barakatun-Nisak MY, Abu Saad H, Ismail S, Hamdy O, Mansour AA. Association of Health Literacy and Nutritional Status Assessment with Glycemic Control in Adults with Type 2 Diabetes Mellitus. Nutrients. 2020;12(10):3152. doi: 10.3390/nu12103152.
• Hussein SH, Albatineh AN, Almajran A, Ziyab AH. Association of health literacy and other risk factors with glycemic control among patients with type 2 diabetes in Kuwait: A cross-sectional study. Primary Care Diabetes. 2021;15(3):571-577. doi: 10.1016/j.pcd.2021.01.011.
• Khatiwada B, Rajbhandari B, Mistry SK, Parsekar S, Yadav UN. Prevalence of and factors associated with health literacy among people with Noncommunicable Diseases (NCDs) in South Asian countries: A systematic review. Clin Epidemiology Glob Health. 2022;18:101174. doi: 10.1016/j.cegh.2022.101174.
• Rajah R, Hassali MAA, Murugiah MK. A systematic review of the prevalence of limited health literacy in Southeast Asian countries. Public Health. 2019;167:8-15. doi: 10.1016/j.puhe.2018.09.028.
• Saleh A, Wirda W, Irwan AM, Latif AI. The relationships among self-efficacy, health literacy, self-care and glycemic control in older people with type 2 diabetes mellitus. Working with Older People. 2021;25(2):164-169. doi: 10.1108/ wwop-08-2020-0044.
• Choudhry NK, Kronish IM, Vongpatanasin W, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(1):e1-e14. doi: 10.1161/ HYP.0000000000000203.
• Elnaem MH, Mosaad M, Abdelaziz DH, et al. Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review. Int J Environ Res Public Health. 2022;19(21):14571. doi: 10.3390/ijerph192114571
• Keasley J, Oyebode O, Shantikumar S, et al. A systematic review of the burden of hypertension, access to services and patient views of hypertension in humanitarian crisis settings. BMJ Glob Health. 2020;5(11):e002440. doi: 10.1136/bmjgh-2020-002440.
• Alawneh IS, Yasin A, Musmar S. The Prevalence of Uncontrolled Hypertension among Patients Taking Antihypertensive Medications and the Associated Risk Factors in North Palestine: A Cross-Sectional Study. Adv Med Sci. 2022;2022:5319756. doi: 10.1155/2022/5319756
• Rahman A, Biswas J, Banik PC. Non-communicable diseases risk factors among the forcefully displaced Rohingya population in Bangladesh. PLOS Global Public Health. 2022;2(9). doi: 10.1371/journal.pgph.0000930.
• Lossius MI, Alfstad KÅ, Aaberg KM, Nakken KO. Discontinuation of antiepileptic drugs in seizure-free patients - when and how? Journal of the Norwegian Medical Association. 2017;137(6):451-454. doi: 10.4045/tidsskr.16.0957.
• Caqueo-Urízar A, Urzúa A, Mena-Chamorro P, Bravo de la Fuente J. Effects of Adherence to Pharmacological Treatment on the Recovery of Patients with Schizophrenia. Healthcare. 2021;9(9):1230. doi: 10.3390/healthcare9091230.
• Banerjee S, Varma RP. Factors affecting non-adherence among patients diagnosed with unipolar depression in a psychiatric department of a tertiary hospital in Kolkata, India. Depress Res Treat. 2013;2013:809542.
• Graeupner D, Coman A. The dark side of meaning-making:How social exclusion leads to superstitious thinking. J Exp Soc Psychol. 2017;69:218-222.
• Puckree T, Mkhize M, Mgobhozi Z, Lin J. African traditional healers: what health care professionals need to know. Int J Rehabil Res. 2002;25(4):247-251. doi: 10.1097/00004356-200212000-00001.
• Taher M, Pashaeypoor S, Cheraghi MA, Karimy M, Hoseini ASS. Superstition in health beliefs: Concept exploration and development. Fam Med Prim Care Rev. 2020;9(3):1325-1330. doi: 10.4103/jfmpc.jfmpc_871_19.
• Grim BJ, Grim ME. Belief, Behavior, and Belonging: How Faith is Indispensable in Preventing and Recovering from 159Case of multisystem in ammatory syndrome in adults Substance Abuse. J Relig Health. 2019;58(5):1713-1750. doi: 10.1007/s10943-019-00876-w.
• Mirahmadizadeh A, Delam H, Seif M, Banihashemi SA, Tabatabaee H. Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia. Iran J Med Sci. 2019;44(3):204213.
• Félix IB, Henriques A. Medication adherence and related determinants in older people with multimorbidity: a cross‐ sectional study. Nursing Forum. 2021;56:834-843. doi: 10.1111/nuf.12619.
• Chippa V, Roy K. Geriatric Cognitive Decline and Polypharmacy. National Library of Medicine. https://www.ncbi. nlm.nih.gov/books/NBK574575/. Published January 2022. Accessed November 18, 2022.
• Varghese D, Ishida C, Koya HH. Polypharmacy. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/ NBK532953/. Published January 2022. Accessed November 18, 2022.
• Santer M, Ring N, Yardley L, Geraghty AW, Wyke S. Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers’ views. BMC Pediatrics. 2014;14:63. doi: 10.1186/1471-2431-14-63.
• Al-Hassany L, Kloosterboer SM, Dierckx B, Koch BC. Assessing methods of measuring medication adherence in chronically ill children-a narrative review. Patient Preference and Adherence. 2019;13:1175-1189. doi: 10.2147/ PPA.S200058.
• Wu YY, Luo YY, Huang LF, et al. Prevalence and risk factors of medication non-adherence in children with inflammatory bowel disease. Zhonghua Er Ke Za Zhi. 2022;60(11):1191-1195. doi:10.3760/cma.j.cn112140-20220110-00036
• Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86. doi: 10.2147/tcrm.s1458.
• Wilder ME, Kulie P, Jensen C, et al. The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med. 2021;36(5):1359-1370. doi: 10.1007/s11606-020-06447-0.
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi: 10.3389/fphar.2013.00091.
• Bosworth HB, Blalock DV, Hoyle RH, Czajkowski SM, Voils CI. The role of psychological science in efforts to improve cardiovascular medication adherence. Am Psychol. 2018;73(8):968-980. doi: 10.1037/amp0000316
• Correia S, Correia A, Videira I, et al. Health gains of telephone follow-up nursing intervention to patient with heart disease. Gerontechnology. 2019:107-113. doi:10.1007/9783-030-16028-9_10
• Tan CS. The Need of Patient Education to Improve Medication Adherence Among Hypertensive Patients. Malays J Pharm Sci. 2020;6(1):1-5. doi: 10.52494/moel1486.
• Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81-95. doi: 10.1007/s12160-013-9486-6.
• Howren MB, Gonzalez JS. Treatment adherence and illness self-management: introduction to the special issue. J Behav Med. 2016;39(6):931-934. doi: 10.1007/s10865-0169804-0.
• Bahri P, Harrison-Woolrych M. Focusing on risk communication about medicines: why now?. Drug Safety. 2012;35(11):971-975. doi: 10.1007/BF03261984.
• Fukuda Y, Ando S, Saito M. Risk awareness, medication adherence, and driving behavior as determined by the provision of drug information to patients. Patient Educ Couns. 2020;103(8):1574-1580. doi: 10.1016/j.pec.2020.02.037.

Identifiers

DOI

10.15584/ejcem.2023.1.19

Biblioteka Nauki

2211816